Jian-Hua Mao Selected Research

Immunoglobulin G (IgG)

6/2021	Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review.
8/2015	High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian-Hua Mao Research Topics

Disease

89	Neoplasms (Cancer) 01/2024 - 04/2002
19	Breast Neoplasms (Breast Cancer) 02/2024 - 10/2007
17	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2010
9	Carcinogenesis 01/2021 - 08/2007
7	Neoplasm Metastasis (Metastasis) 06/2020 - 03/2013
5	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2023 - 01/2018
5	Inflammation (Inflammations) 10/2021 - 03/2009
5	Lymphoma (Lymphomas) 01/2021 - 12/2004
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2016
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 08/2007
4	Genomic Instability 10/2021 - 06/2014
4	Leukemia 01/2021 - 03/2008
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2017 - 03/2009
4	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 05/2012
3	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2022
3	Infections 11/2021 - 05/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020 - 01/2018
3	Adenocarcinoma of Lung 01/2018 - 01/2012
3	Carcinoma (Carcinomatosis) 12/2014 - 08/2003
3	Acute Promyelocytic Leukemia 06/2011 - 03/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2013
2	Cardiotoxicity 01/2023 - 01/2023
2	Intellectual Disability (Idiocy) 01/2022 - 10/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2007
2	Adenocarcinoma 01/2022 - 11/2019
2	Proteinuria 06/2021 - 02/2015
2	Cytomegalovirus Infections (Inclusion Disease) 05/2016 - 03/2016
2	Mesothelioma 10/2015 - 02/2011
2	Malignant Mesothelioma 09/2012 - 02/2011
2	Papilloma (Papillomatosis) 05/2006 - 08/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2024
1	Non-alcoholic Fatty Liver Disease 05/2024
1	Systemic Vasculitis 10/2023
1	Vasculitis (Vasculitides) 10/2023

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2007
13	Biomarkers (Surrogate Marker)IBA 05/2024 - 09/2008
10	Messenger RNA (mRNA)IBA 01/2018 - 01/2010
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2002
7	CytokinesIBA 03/2022 - 04/2011
7	Small Interfering RNA (siRNA)IBA 01/2016 - 10/2007
7	Estrogen ReceptorsIBA 12/2014 - 01/2010
6	Cullin Proteins (Cullins)IBA 01/2021 - 02/2011
5	Oncogene Proteins (Oncogene Protein)IBA 06/2020 - 03/2008
5	Sirolimus (Rapamycin)FDA Link 01/2018 - 09/2008
5	Phenobarbital (Luminal)FDA Link 10/2017 - 08/2010
4	salicylhydroxamic acid (SHAM)IBA 06/2022 - 12/2014
4	CarcinogensIBA 01/2021 - 08/2010
4	Long Noncoding RNAIBA 01/2018 - 05/2012
4	Ligases (Synthetase)IBA 01/2017 - 12/2004
4	Casein Kinase II (Casein Kinase 2)IBA 11/2013 - 05/2009
3	SmokeIBA 01/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 10/2021 - 05/2012
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2021 - 12/2015
3	Phosphotransferases (Kinase)IBA 02/2021 - 01/2013
3	ArsenicIBA 02/2017 - 12/2010
3	UbiquitinIBA 01/2017 - 12/2004
3	Aurora Kinase AIBA 03/2013 - 02/2007
2	AzoxymethaneIBA 01/2024 - 01/2021
2	Genetic Markers (Genetic Marker)IBA 01/2023 - 01/2023
2	AnthracyclinesIBA 01/2023 - 01/2023
2	EnzymesIBA 01/2022 - 09/2008
2	Immunoglobulin G (IgG)IBA 06/2021 - 08/2015
2	Interleukin-10 (Interleukin 10)IBA 06/2021 - 03/2016
2	Immunoglobulin A (IgA)IBA 06/2021 - 02/2015
2	CholesterolIBA 06/2021 - 12/2015
2	huai qi huangIBA 06/2021 - 08/2017
2	Cisplatin (Platino)FDA LinkGeneric 06/2020 - 06/2014
2	Tobacco Smoke Pollution (Passive Smoking)IBA 03/2020 - 01/2019
2	antineoplaston A10 (A 10)IBA 05/2019 - 12/2004
2	Peptides (Polypeptides)IBA 01/2018 - 06/2017
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 12/2010
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2017 - 12/2010
2	Cadherins (E-Cadherin)IBA 01/2017 - 12/2014
2	Air Pollutants (Pollutants, Air)IBA 10/2016 - 09/2016
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2016 - 05/2006
2	Gemcitabine FDA Link 01/2016 - 12/2015
2	Proline (L-Proline)FDA Link 01/2016 - 01/2012
2	Serine (L-Serine)FDA Link 02/2015 - 01/2012
2	hemateinIBA 11/2013 - 05/2009
2	Glutamic Acid (Glutamate)FDA Link 01/2013 - 01/2012
2	Therapeutic UsesIBA 06/2011 - 03/2009
2	Environmental CarcinogensIBA 04/2011 - 02/2003
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2024
1	AcidsIBA 05/2024
1	alpha-Linolenic Acid (Linolenic Acid)IBA 05/2024
1	Bile Acids and Salts (Bile Acids)IBA 05/2024
1	Dopamine Agonists (Dopamine Agonist)IBA 02/2024
1	Cabergoline FDA LinkGeneric 02/2024
1	Calcibiotic Root Canal SealerIBA 01/2024
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2023

Therapy/Procedure

20	Therapeutics 01/2024 - 09/2005
9	Drug Therapy (Chemotherapy) 11/2020 - 08/2010
6	Radiotherapy 12/2023 - 01/2010
4	Transplantation 01/2021 - 01/2008
3	Fecal Microbiota Transplantation 01/2023 - 01/2020
2	Immunotherapy 01/2023 - 01/2022
2	Aftercare (After-Treatment) 05/2016 - 08/2004
2	Investigational Therapies (Experimental Therapy) 07/2015 - 06/2014
1	Chemoprevention 02/2024